CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
![CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine](https://thevaccinereaction.org/wp-content/uploads/2024/04/Penbraya-1024x682.png)
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]